Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
WST holding history
West Pharmaceutical Services Inc in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
WST overviewAll 13F holders of WSTFull Q2 2026 holdings
- Shares (Q2 2026)
- 181,384
- Value
- $65.1M
- % of portfolio
- 0.2%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 181,384 | $65.1M | 0.2% | +181,384 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −118,276−100.0% | Sold out | Holders |
| Q4 2024 | 118,276 | $38.7M | 0.1% | +17,985+17.9% | Added | Holders |
| Q3 2024 | 100,291 | $30.1M | 0.1% | +615+0.6% | Added | Holders |
| Q2 2024 | 99,676 | $32.8M | 0.1% | −1,504−1.5% | Reduced | Holders |
| Q1 2024 | 101,180 | $40.0M | 0.1% | −19,416−16.1% | Reduced | Holders |
| Q4 2023 | 120,596 | $42.5M | 0.1% | −20,838−14.7% | Reduced | Holders |
| Q3 2023 | 141,434 | $53.1M | 0.2% | +5,528+4.1% | Added | Holders |
| Q2 2023 | 135,906 | $52.0M | 0.2% | +53,507+64.9% | Added | Holders |
| Q1 2023 | 82,399 | $28.5M | 0.1% | −43,489−34.5% | Reduced | Holders |
| Q4 2022 | 125,888 | $29.6M | 0.1% | −39,585−23.9% | Reduced | Holders |
| Q3 2022 | 165,473 | $40.7M | 0.1% | −29,020−14.9% | Reduced | Holders |
| Q2 2022 | 194,493 | $58.8M | 0.2% | +5,779+3.1% | Added | Holders |
| Q1 2022 | 188,714 | $77.5M | 0.2% | −494−0.3% | Reduced | Holders |
| Q4 2021 | 189,208 | $88.7M | 0.2% | +50,654+36.6% | Added | Holders |
| Q3 2021 | 138,554 | $58.8M | 0.1% | −8,536−5.8% | Reduced | Holders |
| Q2 2021 | 147,090 | $52.8M | 0.1% | −12,221−7.7% | Reduced | Holders |
| Q1 2021 | 159,311 | $44.9M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.